PTC Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.12.17	Schubert Firm Launches Investigation Of PTC Therapeutics, Inc. Executives For Potential Breaches Of Fiduciary Duty (PR Newswire)
01.12.17	In The Spotlight: Zogenix (RTTNews)
20.11.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
20.11.17	Historic Groundbreaking of First Stand-Alone Inpatient Detox Center in Maryland (PR Newswire)
02.11.17	PTC Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
26.10.17	It's A No For PTCT As Expected, SRPT Revises Outlook Higher, TSRO Gets FDA Nod (RTTNews)
25.10.17	PTC Therapeutics Receives Complete Response Letter for Ataluren's NDA (PR Newswire)
24.10.17	PTC Therapeutics to Present at the Credit Suisse 26th Annual Healthcare Conference (PR Newswire)
23.10.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
19.10.17	PTC Therapeutics to Host Conference Call to Discuss Third Quarter Financial Results (PR Newswire)
14.10.17	PTC THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of PTC Therapeutics, Inc. - (PTCT) (PR Newswire)
12.10.17	Spinal Muscular Atrophy Program Advances into Pivotal Study in SMA Patients (PR Newswire)
05.10.17	Inedo Recognized in the 2017 Gartner Magic Quadrant for Application Release Automation (PR Newswire)
04.10.17	CLSN Is Hot & Newsy, CTMX Soars On AMGN Deal, SUNFISH Fails To Help PTCT Shine (RTTNews)
04.10.17	ECYT On A Roll, MannKind Delighted, DRRX Gains On Patent Deal, PTCT Slumps (RTTNews)
03.10.17	RG7916 Increased SMN Protein Production in SUNFISH Clinical Trial in Patients with Type 2/3 Spinal Muscular Atrophy (PR Newswire)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
29.09.17	PTCT's Quest For Approval Of DMD Drug Translarna (RTTNews)
27.09.17	Long-Term PTC Investors: Johnson Fistel Initiates Investigation of PTC Therapeutics, Inc.; Encourages Investors to Contact the Firm (PR Newswire)
27.09.17	AXON Depressed By MINDSET, CDNA On Track, PTCT On A Sticky Wicket? (RTTNews)
21.09.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
21.09.17	Strong Global Markets Help Asset Managers' Operating Margins Recover In The Second Quarter, But Industry Likely Continues To Face Fee Pressures, According To DST (PR Newswire)
07.09.17	PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition of World Duchenne Awareness Day (PR Newswire)
06.09.17	Appeal of Conscience Foundation Will Honor Corporate Global Leaders From United States, Europe and Asia: Brian Moynihan, Chairman and CEO of Bank of America, Paul Polman, Chief Executive Officer of... (PR Newswire)
05.09.17	Dutch Boy® Paints Names Sandstone Tint As 2018 Color Of The Year (PR Newswire)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
23.08.17	Gainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA... (RTTNews)
10.08.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
08.08.17	PTC Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update (PR Newswire)
25.07.17	PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results (PR Newswire)
18.07.17	PTC Therapeutics Announces Publication of Data from ACT DMD in The Lancet (PR Newswire)
10.07.17	Daily Technical Summary Reports on Biotech Stocks -- PTC Therapeutics, Portola Pharma, Regeneron Pharma, and Seattle Genetics (PR Newswire)
02.07.17	AEZS Makes Second Try For Macrilen, IPCI To Face FDA Panel, PTCT On Watch (RTTNews)
02.07.17	PTC : Preliminary Phase 2 Data From Spinal Muscular Atrophy Program Presented (RTTNews)
01.07.17	Preliminary Phase 2 Data from Spinal Muscular Atrophy Program Presented at CureSMA Conference (PR Newswire)
30.06.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
30.06.17	Company Spotlight: PTC Therapeutics (RTTNews)
22.06.17	New Analyses of Translarna™ (ataluren) Data from ACT DMD Presented at the 12th Annual European Pediatric Neurology Society Congress (PR Newswire)
08.06.17	Gainers & Losers Of June 7: NH, CRUS, PTCT, ANAB, ACRX... (RTTNews)
07.06.17	FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz (RTTNews)
06.06.17	PTC Therapeutics Announces FDA Advisory Committee Meeting for Ataluren for the Treatment of Nonsense Mutation Dystrophinopathy (PR Newswire)
02.06.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
23.05.17	Biotech Stocks on Investors' Radar -- Ophthotech, Pacific Biosciences of California, PTC Therapeutics, and Portola Pharma (PR Newswire)
19.05.17	PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
09.05.17	Gainers & Losers Of May 8: DRRX, CXRX, URGN, ARLX, TXMD... (RTTNews)
08.05.17	Star Micronics and Elo Partner to Provide a Modernized All-In-One POS Solution (PR Newswire)
24.04.17	PTC Therapeutics to Host Conference Call to Discuss First Quarter Financial Results (PR Newswire)
20.04.17	PTC Therapeutics Completes Acquisition of Emflaza™ for the Treatment of Duchenne Muscular Dystrophy in the U.S. (PR Newswire)
12.04.17	Invesco Ltd. To Announce First Quarter 2017 Results (PR Newswire)
10.04.17	PTC Therapeutics Announces Departure of Chief Financial Officer, Shane Kovacs (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu PTC Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten